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Univers
osting by E
cense.Abstract A facile synthesis of 3-[(4-chloro-3-methylphenoxy)methyl]-6-aryl-5,6-dihydro-[1,2,4]-
triazolo[3,4-b][1,3,4]thiadiazoles 3a–n has been achieved by microwave promoted condensation of
3-mercapto-4-amino-5-[(4-chloro-3-methylphenoxy)methyl]-4H-1,2,4-triazole 1 with various aro-
matic aldehydes 2a–n in presence of catalytic amount of p-TsOH (para-toluenesulphonic acid).
The structures of 3a–n are supported by IR and 1H and 13C NMR spectral data.
ª 2010 King Saud University. Open access under CC BY-NC-ND license.1. Introduction
It has been reported that several triazoles and their heterocy-
clic derivatives represent an interesting class of compounds
possessing a wide spectrum of biological activities. A large
number of triazole-containing ring systems exhibit anti-fungal2632 255095.
(J.P. Raval).
ity.
lsevier(Holla et al., 1996), anti-bacterial (Pandeya et al., 2000), anti-
viral (Papakonstantinou-Garoufalias et al., 1998), anti-convul-
sant (Husain and Amir, 1986) properties. Likewise thiadiazole
derivatives are known to have wide variety of biological activ-
ities like CNS-depressants (Jadav et al., 2008; Mohammad
et al., 2008), anti-convulsant (Mohammad et al., 2008), antitu-
bercular (Foroumadi et al., 2003; Talath and Gadad, 2006),
anti-cancer (Rzeski et al., 2007), analgesic (Schenone et al.,
2006) and anti-inﬂammatory (Liu et al., 2008) and antimicro-
bial activities (Liu et al., 2008; Nanjunda Swamy et al., 2006).
Furthermore, 1,2,4-triazolothiadiazoles system also possesses
diverse biological activities such as anti-inﬂammatory (Math-
ew et al., 2006, 2007), analgesic (Mohd et al., 2008), anti-viral
(Invidiata et al., 1996), anti-bacterial (Nanjunda Swamy et al.,
2006; Invidiata et al., 1991, 1996; Karthikeyan et al., 2007),
anti-fungal (Nanjunda Swamy et al., 2006; Karthikeyan
et al., 2007) activities. It has also been recently reported that
Table 1 Comparison of microwave and conventional tech-
nique for compounds 3a–n.
Entry R Yield Reaction time
MWI
(in %)
Conv.
(in %)
MWI
(min)
Conv.
(h)
Y1
a Y2 t1
a t2
3a H 75 84 57 4.0 3.0 10
3b 2-Cl 83 90 54 6.0 2.0 12
3c 3-Cl 86 91 61 5.5 2.5 11
3d 4-Cl 81 86 59 5.5 2.0 12
3e 2-OCH3 79 88 47 4.5 2.0 12
3f 4-OCH3 77 83 48 5.0 2.5 12
3g 2,4-(OCH3)2 73 85 40 5.5 3.5 11
3h 2-NO2 81 90 57 5.0 3.5 10
3i 4-NO2 79 88 51 5.0 3.0 10.5
3j 3-Br 83 92 43 6.0 3.5 12
3k 2,4-(Cl)2 72 82 59 4.5 2.0 10.5
3l 2,6-(Cl)2 70 82 55 5.0 3.5 10.5
3m 2-OH 74 83 63 5.0 3.0 11
3n 3-OH 77 87 60 5.5 3.5 11
MWI =microwave method, Conv. = conventional method.
a Y1 and t1 at power p1 = 350 W and Y2 and t2 at power
p2 = 500 W.
418 J.P. Raval et al.some 3-methyl or benzyl 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole
derivatives are endowed with anti-HIV-1 activity at subcyto-
toxic concentrations (Wallis et al., 1999). In view of these facts
and as a continuation (Raval and Desai, 2005, 2009; Raval
et al., 2009) of our research on the biological properties of tri-
azole containing derivatives we have designed and synthesized
a number of 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
derivatives using microwave irradiation.
Microwave heating has emerged as a powerful technique to
promote a variety of chemical reactions (Lidstrom et al., 2001).
Microwave reactions under solvent-free conditions are attrac-
tive in offering reduced pollution, low cost besides offering
high yields together with simplicity in processing and handling
(Adam, 2003). The recent introduction of single-mode technol-
ogy (Hayes, 2002) assures safe and reproducible experimental
procedures and microwave synthesis has gained acceptance
and popularity among the synthetic chemist community. The
application of microwave irradiation to organic synthesis has
been the focus of considerable attention in recent years and
is becoming an increasingly popular technology (Kidwai,
2001). Microwave irradiation has been also applied to carry
out synthesis in open vessel (Loupy et al., 2001; Anastas and
Warner, 1998; Anastas and Williamson, 1998; Varma, 1999)
using organic solvents such as ethanol, N,N-dimethylformam-
ide (DMF), 1,2-dichloroethane (DCE), 1,2-dichlorobenzene as
energy transfer media which absorb microwave energy efﬁ-
ciently through dipole rotation. Under the work of Green
Chemistry and in continuation to our earlier work (Raval
et al., 2006, 2008, 2009) on the application of microwaves to
organic synthesis we have developed an environmentally be-
nign method for incorporation of 1,2,4-triazoles and thiadiaz-
oles in one frame work and hope to obtain a few compounds
having better anti-fungal, anti-bacterial and anti-inﬂammatory
activities.
The synthesis of novel 3-[(4-chloro-3-methylphenoxy)
methyl]-6-aryl-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles
3a–n is achieved by condensation of 3-mercapto-4-amino-5-
[(4-chloro-3-methylphenoxy)methyl]-4H-1,2,4-triazole 1 withCl
H3C
O N
N
N
H2N
SH
i(a)/i(b
1
Where
i(a) Conventional method: p-TsOH / DMF, re
i(b) Microwave method: p-TsOH / DMF/acid
t1 = 4.0-6.0 mins at p1 = 350w, t2 = 2.0-3.5
Ar = C6H5 (2a, 3a), 2-OCH3-C6H4 (2e, 3e),
2-Cl-C6H4 (2b, 3b), 4-OCH3-C6H4 (2f , 3f),
3-Cl-C6H4 (2c, 3c), 2,4:(OCH3)-C6H3 (2g, 3
4-Cl-C6H4 (2d, 3d), 2-NO2-C6H4 (2h, 3h),
Ar - CHO
Schemevarious aromatic aldehydes 2a–n in the presence of catalytic
amount of p-TsOH in DMF (20 mL) in borosil beaker under
microwaves irradiation (Scheme 1). The same compounds have
been also synthesized using conventional approach. A compar-
ative study in terms of yield and reaction period is also re-
ported using conventional method (Table 1).2. Experimental
All the melting points were determined on a Cintex melting
point apparatus and are uncorrected. The IR-spectra wereS
N
HN
N
N
Ar
O
H3C
Cl
)
2a-n
3a-n
f lux, 10-12 hours
ic alumina, µw,
min at p2 = 500w
4-NO2-C6H4 (2i, 3i), 2-OH-C6H4 (2m, 3m),
3-Br-C6H4 (2j, 3j), 3-OH-C6H4 (2n, 3n)
g), 2,4:(Cl)2-C6H3 (2k, 3k),
2,6-(Cl)2-C6H3 (2l, 3l),
1
A convenient, rapid microwave assisted synthesis of some novel 419recorded on Perkin–Elmer 783 Spectrophotometer and 1H
NMR spectra in CDCl3 (Chemical shifts in d ppm) on Hit-
achi-1200 (60 MHz) Spectrometer using TMS as an internal
standard, 13C NMR on a Varian AMX 400 (100 MHz) spec-
trometer as solutions in CDCl3. The purity of the synthesized
compounds have been tested by thin-layer chromatography on
silica-gelG (acetone:benzene; 3:7). Themicrowave assisted reac-
tions are conducted in a ‘‘QPro-M Microwave Synthesis Sys-
tem’’ manufactured by Questron Technologies Corporation,
Ontario L4Z 2E9 Canada, whereby microwaves are generated
bymagnetron at a frequency of 2450 MHz having an output en-
ergy range of 100–500 W and with an individual sensor for tem-
perature control (ﬁber optic is used as a individual sensor for
temperature control) with attachment of reﬂux condenser with
constant stirring (thus avoiding the risk of high pressure devel-
opment) and synthesis on preparative scales. Elemental analysis
was performed on Carlo Erba-1108 analyzer. All the com-
pounds were analyzed for C, H, and N analysis and the values
were found within ±0.5% of the theoretical values (Table 1).
2.1. General procedure for synthesis of 3-mercapto-4-amino-5-
[(4-chloro-3-methylphenoxy)methyl]-4H-1,2,4-triazole (1)
The starting compound was prepared by reported literature
(Ried and Heindel, 1976).
2.2. General procedure for synthesis of 3-[(4-chloro-3-
methylphenoxy)methyl]-6-aryl-5,6-dihydro-
[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole (3a–n)
2.2.1. Conventional method
An equimolar mixture of 3-mercapto-4-amino-5-[(4-chloro-3-
methylphenoxy)methyl]-4H-1,2,4-triazole (1) (2.70 g, 0.01 mol),
benzaldehyde (2a) (1.06 g, 0.01 mol) and p-TsOH (50 mg,
0.003 mol) in dry DMF (50 mL) was reﬂuxed for 10–12 h,
cooled, and poured onto crushed ice. The isolated product
was crystallized from methanol as light-yellow needle shaped
crystals. Similarly, compounds 3b–n were prepared and their
characterization data are given in Table 1.
2.2.2. Microwave method
A solution of 3-mercapto-4-amino-5-[(4-chloro-3-methylphen-
oxy)methyl]-4H-1,2,4-triazole (1) (2.70 g, 0.01 mol), benzalde-
hyde (2a) (1.06 g, 0.01 mol) and p-TsOH (50 mg, 0.003 mol)
in dry DMF (20 mL) was absorbed over acidic alumina
(20 g) at room temperature. The mixture was mixed, dried
and kept inside the alumina bath and subjected to microwave
irradiation in microwave oven at power output of 350 W (for
4.0–6.0 min) and 500 W (for 2.0–3.5 min) as shown in Table
1. After the completion of reaction (monitored using TLC),
the mixture was cooled and the product was extracted with
dry toluene. The solid thus separated was ﬁltered, washed
thoroughly with water and crystallized from methanol.
2.2.2.1. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-phenyl-5,6-
dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole (3a). M.p.
186–188 C; 1H NMR (CDCl3) (d/ppm): 2.26 (s, 3H, CH3),
4.09 (s, 1H, C6–H), 5.15 (d, 2H, J= 7.6 Hz, OCH2), 5.77
(bs, 1H, –CH–NH–), 6.96–8.21 (m, 8H, ArH); 13C NMR
(CDCl3) (d/ppm): 20.0 (CH3), 64.6 (C-6), 66.8 (OCH2),
114.4, 125.9, 126.7, 127.1, 128.2, 128.7, 129.5, 129.8 (Ar–C),130.1 (C–Cl), 133.1 (C–CH3), 151.7, 158.7 (triazole-C3,5),
159.2 (ArC–OCH2–); IR (m/cm
1): 3180 (NH); 3010 (polynu-
clear aromatic CH hydrocarbons), 1630 (C‚N), 1545–1550
(NH bending); 1430 (N‚N), 1510 (C–N), 1525 (C'C aro-
matic), 2910, 2870, 1425 and 715 (CH2 and CH3), 1225 and
1044 (C–O–C), 615–620 (C–S–C), 770–720 (C–Cl), respec-
tively. Anal. Calc. for C17H15ON4SCl (358.50): C, 56.90; H,
4.21; N, 15.61. Found: C, 56.83; H, 4.16; N, 15.53.
2.2.2.2. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(2-chloro-
phenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
(3b). M.p. 200–203 C; 1H NMR (CDCl3) (d/ppm): 2.11 (s,
3H, CH3), 4.01 (s, 1H, C6–H), 5.11 (d, 2H, J= 7.6 Hz,
OCH2), 5.71 (bs, 1H, –CH–NH–), 7.01–7.21 (m, 7H, Ar–H);
13C NMR (CDCl3) (d/ppm): 20.1 (CH3), 64.5 (C-6), 66.7
(OCH2), 114.7, 125.5, 126.7, 127.1, 128.7, 129.1, 129.4 (Ar–
C), 129.9 (C–Cl), 133.0 (C–CH3), 151.5, 158.6 (triazole-C3,5),
159.1 (ArC–OCH2–); IR (m/cm
1): 3190 (NH), 615 (C–S–C),
770 (C–Cl). Anal. Calc. for C17H14ON4SCl2 (393.30): C,
51.92; H, 3.59; N, 14.25. Found: C, 51.90; H, 3.55; N, 14.20.
2.2.2.3. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(3-chloro-
phenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
(3c). M.p. 182–184 C; 1H NMR (CDCl3) (d/ppm): 2.09 (s,
3H, CH3), 4.02 (s, 1H, C6–H), 5.16 (d, 2H, J= 7.6 Hz,
OCH2), 5.69 (bs, 1H, –CH–NH–), 7.11–7.50 (m, 7H, Ar–H);
13C NMR (CDCl3) (d/ppm): 20.1 (CH3), 64.5 (C-6), 66.7
(OCH2), 114.7, 125.5, 126.7, 127.1, 128.7, 129.0, 129.5 (Ar–
C), 130.2 (C–Cl), 133.1 (C–CH3), 151.5, 158.6 (triazole-C3,5),
159.0 (ArC–OCH2–); IR (m/cm
1): 3190 (NH), 615 (C–S–C),
770 (C–Cl). Anal. Calc. for C17H14ON4SCl2 (393.30): C,
51.92; H, 3.59; N, 14.25. Found: C, 51.89; H, 3.52; N, 14.21.
2.2.2.4. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(4-chloro-
phenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
(3d). M.p. 183–186 C; 1H NMR (CDCl3) (d/ppm): 2.14 (s,
3H, CH3), 4.01 (s, 1H, C6–H), 5.14 (d, 2H, J= 7.6 Hz,
OCH2), 5.71 (bs, 1H, –CH–NH–), 7.01–7.50 (m, 3H, Ar–H),
7.59 (d, 2H, J= 6.1 Hz, Ar–H of 4-Cl C6H5), 7.71 (d, 2H,
J= 6.2 Hz, Ar–H of 4-Cl C6H5);
13C NMR (CDCl3) (d/
ppm): 20.1 (CH3), 64.5 (C-6), 66.7 (OCH2), 114.7, 125.5,
126.7, 127.1, 128.9, 129.2, 129.5 (Ar–C), 131.2 (C–Cl), 133.2
(C–CH3), 151.5, 158.5 (triazole-C3,5), 159.2 (ArC–OCH2–);
IR (m/cm1): 3190 (NH), 615 (C–S–C), 770 (C–Cl). Anal. Calc.
for C17H14ON4SCl2 (393.30): C, 51.92; H, 3.59; N, 14.25.
Found: C, 51.86; H, 3.55; N, 14.22.
2.2.2.5. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(2-methoxy-
phenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
(3e). M.p. 181–183 C; 1H NMR (CDCl3) (d/ppm): 2.18 (s,
3H, CH3), 3.90 (s, 3H, OCH3), 4.11 (s, 1H, C6–H), 5.18 (d,
2H, J= 7.6 Hz, OCH2), 5.77 (bs, 1H, –CH–NH–), 7.07–7.65
(m, 7H, Ar–H); 13C NMR (CDCl3) (d/ppm): 18.9 (CH3),
56.0 (OCH3), 58.9 (C-6), 66.8 (OCH2), 114.9, 125.4, 126.9,
127.2, 128.0, 128.6, 129.1 (Ar–C), 131.7 (C–Cl), 132.2 (C–
CH3), 153.5, 158.1 (triazole-C3,5), 158.9 (ArC–OCH2–); IR
(m/cm1): 3200 (NH), 1250 (C–O), 615 (C–S–C). Anal. Calc.
for C18H17O2N4SCl (388.85): C, 55.60; H, 4.41; N, 14.41.
Found: C, 55.65; H, 4.40; N, 14.33.
2.2.2.6. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(4-methoxy-
phenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
420 J.P. Raval et al.(3f). M.p. 176–178 C; 1H NMR (CDCl3) (d/ppm): 2.14 (s,
3H, CH3), 3.92 (s, 3H, OCH3), 4.20 (s, 1H, C6–H), 5.16 (d,
2H, J= 7.6 Hz, OCH2), 5.79 (bs, 1H, –CH–NH–), 7.22–7.61
(m, 7H, Ar–H); 13C NMR (CDCl3) (d/ppm): 18.9 (CH3),
57.0 (OCH3), 58.1 (C-6), 66.2 (OCH2), 114.9, 128.1, 126.4,
127.1, 127.9, 128.9, 129.2 (Ar–C), 132.1 (C–Cl), 132.9 (C–
CH3), 155.7, 157.1 (triazole-C3,5), 159.9 (ArC–OCH2–); IR
(m/cm1): 3200 (NH), 1245 (C–O), 611 (C–S–C). Anal. Calc.
for C18H17O2N4SCl (388.85): C, 55.60; H, 4.41; N, 14.41.
Found: C, 55.57; H, 4.39; N, 14.37.
2.2.2.7. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(2,4-dime-
thoxyphenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadia-
zole (3g). M.p. 178–180 C; 1H NMR (CDCl3) (d/ppm): 2.11
(s, 3H, CH3), 3.11 (s, 1H, C6–H), 4.01 (s, 6H, OCH3), 5.11
(d, 2H, J= 7.6 Hz, OCH2), 5.77 (bs, 1H, –CH–NH–), 7.21–
7.80 (m, 6H, Ar–H); 13C NMR (CDCl3) (d/ppm): 18.9
(CH3), 56.8 (OCH3), 58.1 (C-6), 66.2 (OCH2), 114.9, 127.9,
127.1, 128.1, 128.9, 129.2 (Ar–C), 132.0 (C–Cl), 132.1 (C–
CH3), 155.7, 157.1 (triazole-C3,5), 159.9 (ArC–OCH2–); IR
(m/cm1): 3200 (NH), 1240 (C–O), 618 (C–S–C). Anal. Calc.
for C19H19O3N4SCl (418.90): C, 54.48; H, 4.57; N, 13.37.
Found: C, 54.40; H, 4.50; N, 13.30.
2.2.2.8. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(2-nitro-
phenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
(3h). M.p. 171–173 C; 1H NMR (CDCl3) (d/ppm): 2.12 (s,
3H, CH3), 3.22 (s, 1H, C6–H), 5.19 (d, 2H, J= 7.6 Hz,
OCH2), 5.72 (bs, 1H, –CH–NH–), 6.82–7.22 (m, 7H, Ar–H);
13C NMR (CDCl3) (d/ppm): 21.1 (CH3), 59.1 (C-6), 66.2
(OCH2), 114.9, 127.1, 127.9, 128.1, 128.9, 129.2, 130.5 (Ar–
C), 131.7 (C–Cl), 132.1 (Ar–CH3), 148.2 (C–NO2), 151.7,
158.1 (triazole-C3,5), 159.9 (ArC–OCH2–); IR (m/cm
1): 3190
(NH), 620 (C–S–C); 1350 (N‚O). Anal. Calc. for
C17H14O3N5SCl (403.85): C, 50.56; H, 3.49; N, 17.34. Found:
C, 50.50; H, 3.45; N, 17.30.
2.2.2.9. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(4-nitro-
phenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
(3i). M.p. 153–155 C; 1H NMR (CDCl3) (d/ppm): 2.11 (s,
3H, CH3), 3.72 (s, 1H, C6–H), 5.11 (d, 2H, J= 7.6 Hz,
OCH2), 5.70 (bs, 1H, –CH–NH–), 6.92–7.12 (m, 7H, Ar–H);
13C NMR (CDCl3) (d/ppm): 21.1 (CH3), 59.1 (C-6), 66.2
(OCH2), 114.7, 114.9, 127.1, 127.9, 128.1, 128.9, 129.2 (Ar–
C), 130.5 (C–Cl), 132.1 (C–CH3), 148.2 (C–NO2), 151.7,
158.1 (triazole-C3,5), 159.9 (ArC–OCH2–); IR (m/cm
1): 3190
(NH), 615 (C–S–C); 1340 (N‚O). Anal. Calc. for
C17H14O3N5SCl (403.85): C, 50.56; H, 3.49; N, 17.34. Found:
C, 50.51; H, 3.40; N, 17.29.
2.2.2.10. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(3-bromo-
phenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
(3j). M.p. 208–210 C; 1H NMR (CDCl3) (d/ppm): 2.09 (s,
3H, CH3), 3.92 (s, 1H, C6–H), 5.11 (d, 2H, J= 7.6 Hz,
OCH2), 5.70 (bs, 1H, –CH–NH–), 6.43–6.83 (m, 7H, Ar–H);
13C NMR (CDCl3) (d/ppm): 20.1 (CH3), 63.8 (C-6), 68.2
(OCH2), 114.7, 114.9, 126.1, 126.9, 127.0, 127.9, 128.7 (Ar–
C), 123.2 (C–Br), 130.5 (C–Cl), 132.1 (C–CH3), 151.7, 158.1
(triazole-C3,5), 158.9 (ArC–OCH2–); IR (m/cm
1): 3210 (NH),
618 (C–S–C str); 660 (C–Br). Anal. Calc. for C17H14ON4SClBr
(437.75): C, 46.64; H, 3.22; N, 12.80. Found: C, 46.60; H, 3.18;
N, 12.77.2.2.2.11. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(2,4-dichlo-
rophenyl)-5,6-dihydro-[1,2,4]triazolo [3,4-b][1,3,4]thiadiazole
(3k). M.p. 173–175 C; 1H NMR (CDCl3) (d/ppm): 2.11 (s,
3H, CH3), 3.31 (s, 1H, C6–H), 5.18 (d, 2H, J= 7.6 Hz,
OCH2), 5.73 (bs, 1H, –CH–NH–), 6.91–7.38 (m, 6H, Ar–H);
13C NMR (CDCl3) (d/ppm): 22.7 (CH3), 59.8 (C-6), 68.0
(OCH2), 114.7, 114.9, 124.2, 125.7, 126.0, 127.1 (Ar–C),
130.5 (C–Cl), 132.1 (C–CH3), 151.2, 157.0 (triazole-C3,5),
158.1 (ArC–OCH2–); IR (m/cm
1): 3200 (NH), 620 (C–S–C);
770 (C–Cl). Anal. Calc. for C17H13ON4SCl3 (427.74): C,
47.74; H, 3.06; N, 13.10. Found: C, 47.70; H, 3.00; N, 13.06.
2.2.2.12. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(2,6-dichlo-
rophenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
(3l). M.p. 179–182 C; 1H NMR (CDCl3) (d/ppm): 2.13 (s,
3H, CH3), 3.11 (s, 1H, C6–H), 5.17 (d, 2H, J= 7.6 Hz,
OCH2), 5.69 (bs, 1H, –CH–NH–), 6.59–7.59 (m, 6H, Ar–H);
13C NMR (CDCl3) (d/ppm): 22.7 (CH3), 59.7 (C-6), 68.2
(OCH2), 114.7, 114.9, 124.0, 125.1, 126.2, 127.0 (Ar–C),
131.5 (C–Cl), 132.3 (C–CH3), 151.7, 158.2 (triazole-C3,5),
159.2 (ArC–OCH2–); IR (m/cm
1): 3210 (NH), 614 (C–S–C);
775 (C–Cl). Anal. Calc. for C17H13ON4SCl3 (427.74): C,
47.74; H, 3.06; N, 13.10. Found: C, 47.69; H, 3.01; N, 13.03.
2.2.2.13. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(2-hydroxy
phenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole (3m).
M.p. 153–155 C; 1H NMR (CDCl3) (d/ppm): 2.12 (s, 3H,
CH3), 3.91 (s, 1H, C6–H), 5.09 (d, 2H, J= 7.6 Hz, OCH2),
5.29 (s, 1H, OH), 5.72 (bs, 1H, –CH–NH–), 7.11–7.69 (m,
7H, Ar–H); 13C NMR (CDCl3) (d/ppm): 20.9 (CH3), 60.9
(C-6), 68.1 (OCH2), 115.7, 115.9, 124.2, 125.2, 126.5, 127.2,
129.1 (Ar–C), 130.5 (C–Cl), 132.1 (C–CH3), 152.2 (C–OH),
152.9, 157.1 (triazole-C3,5), 159.0 (ArC–OCH2–); IR (m/cm
1): 3185 (NH), 612 (C–S–C); 3560 (OH). Anal. Calc. for
C17H15O2N4SCl (374.85): C, 54.47; H, 4.03; N, 14.95. Found:
C, 54.40; H, 4.00; N, 14.90.
2.2.2.14. 3-[(4-Chloro-3-methylphenoxy)methyl]-6-(3-
hydroxyphenyl)-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thia-
diazole (3n). M.p. 123–125 C; 1H NMR (CDCl3) (d/ppm):
2.12 (s, 3H, CH3), 3.92 (s, 1H, C6–H), 5.19 (d, 2H,
J= 7.6 Hz, OCH2), 5.38 (s, 1H, OH), 5.72 (bs, 1H, –CH–
NH–), 7.29–7.79 (m, 7H, Ar–H); 13C NMR (CDCl3) (d/
ppm): 20.9 (CH3), 60.9 (C-6), 68.1 (OCH2), 114.9, 115.0,
124.0, 125.0, 126.1, 129.0, 126.9 (Ar–C), 152.1 (C–OH),
153.0, 157.2 (triazole-C3,5), 130.4 (C–Cl), 132.2 (C–CH3),
159.1 (ArC–OCH2–); IR (m/cm
1): 3185 (NH), 612 (C–S–C);
3560 (OH). Anal. Calc. for C17H15O2N4SCl(374.85): C,
54.47; H, 4.03; N, 14.95. Found:C, 54.42; H, 4.02; N, 14.91.3. Results and discussion
Conventional methodology sometimes has lower yields than
microwave protocols. Microwave irradiation facilitates the
polarization of the molecule under irradiation causing a rapid
reaction to occur. A comparative study in terms of yield and
reaction period is shown in Table 1. All the reactions that used
microwave irradiation were completed in 2.0–6.0 min, whereas
similar reactions under conventional heating (steam bath) at
reﬂux temperatures gave poor yields with comparatively longer
reaction time periods (Table 1), demonstrating that the effect
A convenient, rapid microwave assisted synthesis of some novel 421of microwave irradiation is not purely thermal. Microwave
irradiation facilitates the polarization of the molecules under
irradiation causing rapid reaction to occur. This is consistent
with the reaction mechanism, which involves a polar transition
state (Varma, 1999; Loupy et al., 2001). The effectiveness of
microwave irradiation and conventional heating for the syn-
thesis of compounds 3a–n has been compared. The effects of
irradiation power and time on the reaction were also studied
and the results summarized in Table 1. Under microwave irra-
diation conditions, the yields of 3a–n are high (82–91% at
500 W and 77–81% at 350 W), whereas using conventional
heating the yields are only 43–63%. Thus, high yields of com-
pounds 3a–n were obtained at 500 W for 2.0–3.5 min under
microwave irradiation. Also, this simple and reproducible
technique affords various triazolothiadiazoles with short reac-
tion times, excellent yields, and without the formation of unde-
sirable by-products.
From data of 1H NMR spectra of synthesized compound,
the peaks due to –NH2 and SH, which were present in the
starting amino mercaptotriazole (1), were absent and that fur-
ther conﬁrmed the involvement of these functional groups in
the cyclization of triazole to triazolothiadiazoles. Similarly
the absence of –SH proton and the down ﬁelding of –NH2 pro-
tons (integration for one proton) in the 1H NMR spectra
established that –CHO group of the aromatic aldehydes re-
acted with –SH and –NH2 groups of triazoles and thus con-
verted to dihydro triazolo thiadiazoles. Also, structures of
3a–n were established on the basis of their TLC, elemental
analysis, IR and 13C NMR spectra and it was conﬁrmed that
the results for the synthesized compounds are in good agree-
ments (Haijian et al., 2001a,b).4. Conclusion
A new method for the synthesis of 6-aryl-3-[(4-chloro-3-meth-
ylphenoxy)methyl]-5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thi-
adiazoles 3a–n using microwave irradiation, offers signiﬁcant
improvement over existing procedures and thus helps facile en-
try into a synthesis of variety of triazolothiadiazole derivatives.
Also, this simple and reproducible technique affords various
triazolothiadiazole derivatives with short reaction times, excel-
lent yields, and without formation of undesirable side products.Acknowledgements
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